Tags: Johnson & Johnson

Johnson & Johnson Vaccine Candidate To Begin Phase 3 of Human Trials

Johnson & Johnson will be entering phase three of human trials, including 60,000 participants from three continents. They also continue to look for other possible treatments for coronavirus as their vaccine candidate completes safety and efficacy trials.
1 2

Recommended Stories

Real Time Analytics